Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fufang Lingzhi Anshen Oral Liquid
- Development stage
- Unknown
- Lead developer
- Taizhou Enze Medical Center
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Fufang Lingzhi Anshen Oral Liquid is a Traditional Chinese Medicine (TCM) compound formulation primarily utilized to alleviate cancer-related fatigue (CRF) and improve sleep quality in patients, particularly those with non-small cell lung cancer (NSCLC). The formulation typically contains extracts from *Ganoderma lucidum* (Lingzhi), known for its immunomodulatory and anti-fatigue properties, alongside other sedative and tonic herbs such as *Ziziphus jujuba* var. *spinosa* (Suan Zao Ren) and *Poria cocos* (Fu Ling). It is designed to regulate the body's immune response and mitigate systemic inflammation and oxidative stress associated with malignancy and chemotherapy. Clinical research, including studies conducted by institutions like Taizhou Enze Medical Center, has focused on its potential to reduce pro-inflammatory cytokines such as TNF-alpha and IL-6, thereby improving the overall quality of life for cancer patients.
- Brand names
- Fufang Lingzhi Anshen Oral Liquid
- Other names
- Compound Lingzhi Anshen Oral LiquidCompound Reishi Tranquilizing Oral Liquid复方灵芝安神口服液
02
Targets
TNFA (Tumor necrosis factor alpha (soluble))IL-6 (Interleukin 6)
Beyond the preview
Go deeper on Fufang Lingzhi Anshen Oral Liquid.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Fufang Lingzhi Anshen Oral Liquid.